Shares of Space Exploration Technologies traded below $135 per share this week—the first time the company's stock has breached its initial public offering price since secondary markets opened to qualified buyers in early 2024. The stock closed Thursday at $134.80, down 3.2% from the prior session, with premarket activity showing limited institutional support. Musk's net worth fell to $340 billion from a January peak of $380 billion, driven primarily by the 13% drawdown in SpaceX equity held across family offices and crossover funds.
The retreat follows a broader repricing in late-stage private technology, where companies trading above $50 billion enterprise value have seen secondary valuations compress by an average of 18% since mid-March. SpaceX, last privately valued at $210 billion in a December 2024 tender offer, now sits 8% below that mark in over-the-counter trading. Two factors dominate the narrative: a six-month delay in Starship orbital refueling timelines—critical to NASA's $2.9 billion lunar lander contract—and a 22% pullback in the Nasdaq Aerospace & Defense ETF since February highs. Analysts at Cowen noted that Starlink revenue growth, previously running at 34% year-over-year, has decelerated to 19% in the most recent quarter as subscriber additions in North America and Europe plateau.
The parallel to Meta Platforms' post-IPO experience is instructive but incomplete. Meta fell 49% below its $38 offering price within four months of its May 2012 debut, then required 15 months to reclaim that level. The difference: Meta was a public security subject to continuous disclosure and liquidity rules. SpaceX operates in private markets where price discovery is episodic, driven by quarterly tender offers with $10 million minimum participation thresholds. This structure amplifies volatility in both directions. Family offices that entered at the $125 December 2023 level are now flat; those who bought the $150 March 2024 secondary are down 10%. The repricing reflects not distress but recalibration—allocators are now pricing in a 24-to-30-month timeline for Starship commercialization rather than the 12-to-18-month window Musk indicated in October.
What matters is the knock-on effect in private-market discipline. SpaceX is the single largest holding in Ark Venture Fund ($1.4 billion position) and a top-three position in at least 14 venture funds with assets exceeding $500 million. A sustained trade below IPO creates margin pressure for funds that borrowed against these positions—Cowen estimates $2.2 billion in leveraged exposure across the secondaries market. Meanwhile, launch cadence remains strong: 41 Falcon 9 missions in Q1 2025, up from 36 in Q1 2024, and Starlink now serves 3.8 million subscribers globally. The execution risk is orbital refueling and the Artemis schedule, not core cash generation.
Operators should watch three near-term catalysts. First, NASA's April 15 technical review of Starship docking systems—any extension beyond Q3 2025 will pressure the $210 billion valuation floor. Second, SpaceX's next tender offer, expected in late May with a $500 million total allocation, will set a new reference price for crossover funds marking positions. Third, the Starbase environmental assessment from the FAA, due by June 30, governs launch frequency from Texas—critical to both Starlink constellation completion and Department of Defense contracts worth $1.8 billion over three years.
The $135 breach is a repricing, not a referendum. SpaceX generated an estimated $9 billion in revenue during 2024 and operates at positive free cash flow. The question is whether private markets will tolerate a 23x revenue multiple for a company with lumpy government dependencies and a launch manifest that requires flawless execution over 18 consecutive quarters. The May tender will answer that.